21/03/2026
Many people assume that once a medicine leaves the factory, the job is done.
But in reality, quality must be protected throughout the entire supply chain.
This is where Good Distribution Practice (GDP) becomes critical.
GDP ensures medicines are:
• stored under the correct conditions
• transported safely across long distances
• tracked and documented throughout the supply chain
Because even the highest-quality medicine can become unsafe if distribution standards fail.
Imagine a vaccine exposed to the wrong temperature.
Or a biologic transported without proper monitoring.
The result?
The medicine may no longer be safe or effective for the patient.
That is why pharmaceutical quality does not stop at manufacturing.
It continues through:
• warehouses
• transportation networks
• distribution centers
• hospitals and pharmacies
In global healthcare systems, supply chain integrity is patient safety.
Organizations such as the World Health Organization emphasize Good Distribution Practice as a critical component of pharmaceutical quality systems worldwide.
Because at the end of the supply chain, there is always a patient depending on that medicine.
What do you think is the biggest challenge in maintaining pharmaceutical supply chain quality globally? see
hashtag
hashtag hashtag
hashtag hashtag
Chain